Advances in Gastroesophageal Reflux Disease Management: Exploring the Role of Potassium-Competitive Acid Blockers and Novel Therapies.

Pharmaceuticals (Basel) · 2025 · PMC12115254 · PMID 40430518

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although these early differences did not reach statistical significance, vonoprazan showed better outcomes, particularly in patients with more severe disease (Los Angeles grades C/D).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.